clinical trial · NCT00834431
Famciclovir 500 mg Tablets Under Fasting Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 36
HealthyFamciclovir 500 mg TabletsFamvir® 500 mg Tablets
brief summary
The objective of this study is to compare the relative bioavailability of famciclovir 500 mg tablets (Novopharm Limited) with that of FAMVIR® 500 mg tablets (Novartis) in healthy adult subjects under fasting conditions.
started
Aug 1, 2004
primary completion
Sep 1, 2004
completion
Sep 1, 2004
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Single Dose, Comparative Bioavailability Study of Two Formulations of Famciclovir 500 mg Tablets Under Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol